Apixaban for prophylaxis of thromboembolic outcomes in COVID-19 - Lopes, R D; de Barros e Silva, M PG; Macedo, A VS (The primary results of the APOLLO randomized trial)
Presented at: European Society of Cardiology Scientific Sessions, Barcelona, 2022.